Meghmani Finechem Limited to expand existing Caustic Soda Plant

Meghmani Finechem Limited (MFL)- a Flagship Company of Meghmani Group makes an announcement to expand existing Caustic Soda Plant from 294000 TPA to 400000 TPA with upgrading Captive Power Plant capacity from 96 MW to 132 MW at its Chloroalkali and Derivative Complex at GIDC Dahej, Bharuch. 

The total cost of the project will be about Rs. 230 Crores. This additional Caustic Plant is expected to be operational by March 2022 and will generate additional Revenue of Rs. 250 Cr with optimum utilization.

After this expansion, the installed capacity of Chlorine will be increased to 352000 TPA and Hydrogen to 116 million NM3 per annum. Chlorine and Hydrogen produced from this plant will cater the growing demand from various segments like, Agrochemicals, Pharmaceutical and downstream value chain like Chloromethanes, Hydrogen Peroxide, Epichlorohydrin and CPVC resin. 

This plant will also cater various application segments like Alumina, Soap & Detergent, Paper and Pulp, Agrochemicals, Pharmaceuticals, Textile, Petroleum Refining, Dyes & Pigments. This Expansion Project will be the basic building block for future additions of downstream products, Epichlorohydrin and CPVC resin with ensuring continuous supplies to existing customers. Epichlorohydrin and CPVC Resin plants are expected to be commissioned in FY 2022 and FY 2023 respectively. These major steps of moving forward in Chloroalkali Expansions and Downstream Value Chain, would significantly reduce countries Imports dependency and also save valuable FOREX.

Since last Five years, MFL has brought its business to a significantly higher level and consolidated its position as one of the largest Chloroalkali and Derivatives Complex in India. Further, we have aimed to achieve CAGR @ 35% per annum in coming years and to reach the total Revenue of Rs.2000 Cr in FY 2024, with key contributions from existing Caustic Chlorine, Potash and Derivatives such as Chloromethane, Hydrogen Peroxide, Epichlorohydrin (ECH) and Chlorinated Polyvinyl Chloride (CPVC Resin). 

Revenue share from Derivatives Segment is likely to reach at 54% and rest 46% from Chloroalkali Segment in FY 2024. Thus the Company has taken significant steps to achieve its set VISION to become responsible chemical conglomerate with diversified portfolio, with quality products and satisfactory services.

This expansion further demonstrates our strong leadership in providing continuous supply to Customers during difficult and uncertain situations relating to production continuity and competitiveness in the Region.